Two investigators meetings were organized to support the start-up of the projects awarded to GCT. The first one took place in Warsaw, Poland, and gathered over 20 sites from 3 European countries for the Phase II Ophthalmology study discussion.

The second was organized in Saint-Petersburg, Russia in early October, and was devoted to the training of sites personnel involved in the pediatric Phase III trial in patients with a rare neurological disorder.

Both studies are in the active start-up.